| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Thursday, June 25, 2015 9:43:23 AM
We were wrong: the shorts aren't covering.
The question is: Why?
Out the possibilities below, I'm going with #1:
1. They know they're so out of luck their only option is to keep digging their grave until they get to China and escape that way.
By this I mean that they they're shorting with abandon hoping to drive the price down low enough that they can exit with severe but not catastrophic losses. This might just work given that there may, and I emphasize may be a relative information drought in the coming months (nothing until September 2015).
2. The shorts know something or think they know something we don't and they're shorting in anticipation.
3. The shorts honestly believe that DCVax is junk science and that as soon as a pivotal trial's results comes in, NWBO will collapse like a house of cards. This is seemingly Mr. Giordiano's position.
The question is: Why?
Out the possibilities below, I'm going with #1:
1. They know they're so out of luck their only option is to keep digging their grave until they get to China and escape that way.
By this I mean that they they're shorting with abandon hoping to drive the price down low enough that they can exit with severe but not catastrophic losses. This might just work given that there may, and I emphasize may be a relative information drought in the coming months (nothing until September 2015).
2. The shorts know something or think they know something we don't and they're shorting in anticipation.
3. The shorts honestly believe that DCVax is junk science and that as soon as a pivotal trial's results comes in, NWBO will collapse like a house of cards. This is seemingly Mr. Giordiano's position.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
